COVID-19 Vaccine Latest Update: By 2024, There will not be Enough Vaccines Available to Everyone!

According to sources, on Monday Adar Poonawalla, CEO of the Serum Institute of India, warned that there would not be enough coronavirus vaccines available in the world till 2024 at the earliest.

Adar Poonawalla said in an interview with the Financial Times that Vaccines for coronavirus treatment will take almost four to five years until everybody to be vaccinated on this planet.

adar poonawalla2

According to the Financial Times reports, the CEO of the world’s largest vaccine manufacturer estimated that if the coronavirus shot is two doses of vaccine (such as rotavirus or measles), the world would need more than 14 billion doses.

The Pune-based pharmaceutical giant has partnered with five international pharmaceutical companies, including  Novavax and AstraZeneca, to develop the coronavirus vaccine and has pledged to produce more than 1 billion doses of the vaccine, half of which has pledged to India. In addition to this, SII can also cooperate with the Gamaleya Research Institute in Russia to manufacture the Sputnik vaccine for COVID-19 treatment.

He said that this commitment far surpasses the capabilities of other vaccine manufacturers. I know the whole world wants to be optimistic about this. But, I haven’t heard of anyone approaching even close to this level now, he told the FT.

Just when Indian Health Minister Harsh Vardhan stated that although the date for the potential Covid-19 vaccine to be launched has not yet been determined, Poonawalla decreed the above remarks on the second day, but there are chances that the vaccine is likely to be ready by the first quarter of 2021.

He affirmed that regardless of its paying capacity, the vaccine will be provided first to those who need it most.

He further stated: Issues such as vaccine safety, security, cost, cold chain requirements, equity, and production schedules, etc. have also been considered profoundly.

jpg 3

Regarding the availability and authorization of the vaccine, Health Minister Harsh Vardhan notified that the center is considering urgently approving COVID-19 vaccination, especially among the elderly and high-risk groups. He said: This must be done after the agreement, according to an official statement.

In order to alleviate people’s anxieties about vaccine safety, he said: If people have a trust deficit, I will be the first person to offer myself to receive the coronavirus vaccine.

In addition to this, the “Financial Times” also proclaimed that as part of the agreement between SII and AstraZeneca, the company’s goal is to produce vaccines for 68 countries/regions at a cost of approximately US$3. According to the agreement with Novavax, the vaccine targets 92 countries/regions.

Last week, AstraZeneca PLC suspended the trial of the coronavirus vaccine (recombinant) due to an unexplainable illness. It is also reported that the clinical trial has been paused in other countries such as the United States, Britain, Brazil, and South Africa.

serum institute of india 1595388086

After the developments, India’s top pharmaceutical regulator has asked SII to suspend any new recruitment for the second and third phases of clinical trials of the COVID-9 vaccine until further orders are obtained.

The Serum Institute of India is the world’s largest vaccine manufacturer, producing more than 1.4 billion doses of vaccine each year, which can be used in more than 170 countries/regions to prevent polio, measles, influenza, and other infectious diseases.

At the same time, the global coronavirus death toll has risen to 929,005, with more than 28 million infections on Monday. Due to the outbreak of the COVID-19 pandemic, a global vaccine race is underway, and 9 companies are already in the later phase 3 trials.

When will the COVID-19 vaccine be ready? Will we have a Vaccine before the Election?


See also  India's Coronavirus Pandemic Handling in a Nutshell. How did the exclusive Atma Nirbhar Bharat Notion deteriorate to becoming Parmatma Nirbhar?

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker